Menú
Ser líderes en el campo de la metabolómica por RMN, ofreciendo servicios de alta calidad y soluciones innovadoras para comprender y analizar los perfiles metabólicos con precisión y eficacia. Nuestra visión es impulsar avances significativos en la investigación biomédica y la medicina personalizada proporcionando información valiosa y perspicaz para mejorar la salud humana y el bienestar global. Nos esforzamos por ser reconocidos como un socio de confianza y experto en metabolómica de RMN, contribuyendo al avance científico y proporcionando soluciones que tengan un impacto positivo en la sociedad.
Nuestro equipo tiene más de 100 publicaciones en destacadas revistas científicas de todo el mundo.
Abstract Background: Obesity is related to cardiovascular risk factors (CVRF) such as dyslipidemia, diabetes, and hypertension, which increase mortality. Basic lipid …
Abstract Background and aims: We aimed to assess the associations of exposure to air pollutants and standard and advanced lipoprotein measures, …
Abstract Fetal growth restriction (FGR) affects 5-10% of pregnancies, is the largest contributor to fetal death, and can have long-term …
Abstract Background and aim: Circulating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those …
Abstract Minimally invasive prognostic markers of inflammation and dyslipidemia in individuals with a risk of psychosis, also called «at-risk mental …
Abstract Aims: The aim of this study was to combine nuclear magnetic resonance-based metabolomics and machine learning to find a glucose-independent …
Abstract Atherosclerosis is a chronic inflammatory disease caused by the accumulation of cholesterol in the intima. Proprotein convertase subtilisin/kexin type …
Abstract Objective: Chronic inflammation and immune dysregulation are crucial mechanisms for atherosclerosis in RA. Recent evidence suggests a link via humoral …
